Introducing The NIOX Value into your regular arsenal of asthma patient assessment has the potential to save money for the clinic. Both healthcare costs for unscheduled patient visits due to loss of asthma control and the cost of inhaled steroids are reduced, outweighing the increased cost of performing the tests (Berg 2008) .
Berg J, Lindgren P. Economic evaluation of FENO measurement in diagnosis and 1-year management of asthma in Germany. Respir Med 2008; 102: 219–31.